Filipino scientists will be reviewing the use of Sinovac Biotech’s CoronaVac shot in children after China approved the use of the anti-COVID-19 shot in children and adolescents.
According to Vaccine Expert Panel (VEP) member Dr. Rontgene Solante, they’re already looking into the clinical trial data released by Beijing, who gave the vaccine to subjects age 3 to 17 with positive results.
Solante notes that the procedure for reforming the emergency use authorization (EUA) provided for CoronaVac will be ‘just like how we evaluated and approved the extended indication [of] Pfizer [to] 12 to 15 [year olds].”
Technical Advisory Group’s Dr. Edsel Salvana said the amending of the China vaccine’s EUA will not be ‘automatic’ as it will require Sinovac – the manufacturer – to officially apply for it in the Philippines.
Though Sinovac has yet to apply for a wider delivery scope for their vaccine, Salvana welcomed Beijing’s findings as ‘good news’. He mentions that the discovery will mean more vaccines will be available for the young population to use.
At present, the only vaccine approved for use in children in the country is Pfizer’s anti-coronavirus jab.
“The FDA (Food and Drug Administration) actually just amended the EUA for Pfizer for 12 to 15 years [old],” Salvana disclosed in a text message to Inquirer.
Currently, the national government is in its third month of vaccinations and will be expanding its rollout to the A4 priority group today, which is composed of essential workers.
And so far, the government has administered 5.18 million doses of the COVID-19 vaccine to Filipinos – 1.21 of this population has been fully vaccinated.
Meanwhile, as of June 6, the country’s total infection rate has risen to 1,269,478 – 59,337 of which are active cases.
Want more news like this one? Head over to Nation Builder PH Breaking News Section for the latest updates.
Image credit: Mykola Tys / SOPA Images / LightRocket via Getty Images